- Speciality A-Z
- WMC Hepatology
- WMC Hepatology Editors
- WMC Hepatology Peer Reviewed
- Subscribe to NewsLetter
-
- WMC Hepatology Editors
-
- Stay Connected
- Hepatology RSS Feed
WebmedCentral Hepatology
-
Non Alcoholic Fatty Liver Disease, NAFLD: General Overview of a Multifactorial Disease
Abreviations: NAFLD, Non alcoholic fatty liver disease; NASH, non alcoholic steatohepatitis; HPF, high power field; GH: growth hormone; IGF-1, insulin like growth factor 1; TNF, tumor necrosis factor; IP-10, Interferon gamma induced protein 10; MCP-1, monocytes chemoattractan protein; MTTP, microsomal trygliceride transfer protein; ..
-
Irish Hospital Consultant Views on the Management of Hereditary Haemochromatosis and Analysis of the Differences Between 'Common Practice' and The Management Guidelines Available.
Abstract: Background: 0.05% of those with Northern European lineage carry homozygous mutations in the HFE gene causing iron overload. This is a disease with considerable morbidity, which can be screened for. There are many national and regional protocols in place which are somewhat incongruent with each other. We believe that ma..
-
The Misuse of Interferon Minimizes its Effectiveness in Therapy Eliciting Desensitization And Tachyphylaxis: A Different Administration Schedule May Avoid Relapse of Chronic Hepatis C
Abstract: Interferon (IFN) alpha is the only drug active in the therapy of chronic B and C hepatitis (CHB and CHC) and is active in several types of cancer especially Hairy Cell Leukaemia, Chronic Myeloid Leukaemia and melanoma. The present therapeutic schedules use an almost continuous administration of IFN in spite of the fact..
-
Liver Injury By Experimental Portal Bacteremia: Histogenetic Recovery Study In The Rat
Abstract: To study the histogenetic recovery of hepatic lesions due to portal bacteremia, a complication of some clinical conditions, an experimental animal model had developed. Portal bacteremia was performed in 8-week rats and the morphological recovery of liver was histologically checked 1 to 6 days after bacteria inoculation..
-
True Day Case Laparoscopic Cholecystectomy: Safety And Feasibility In A District General Hospital In The UK
Abstract : Introduction:A prospective audit was undertaken of true day case laparoscopic cholecystectomies performed by a single surgeon in a DGH. The audit aims primarily to ascertain the outcome of the operation and patients’ satisfaction with the experience. Data was analysed to find out factors that led to overnight admissi..
- View all
-
True Day Case Laparoscopic Cholecystectomy: Safety And Feasibility In A District General Hospital In The UK
Abstract : Introduction:A prospective audit was undertaken of true day case laparoscopic cholecystectomies performed by a single surgeon in a DGH. The audit aims primarily to ascertain the outcome of the operation and patients’ satisfaction with the experience. Data was analysed to find out factors that led to overnight admissi..
-
Liver Injury By Experimental Portal Bacteremia: Histogenetic Recovery Study In The Rat
Abstract: To study the histogenetic recovery of hepatic lesions due to portal bacteremia, a complication of some clinical conditions, an experimental animal model had developed. Portal bacteremia was performed in 8-week rats and the morphological recovery of liver was histologically checked 1 to 6 days after bacteria inoculation..
-
The Misuse of Interferon Minimizes its Effectiveness in Therapy Eliciting Desensitization And Tachyphylaxis: A Different Administration Schedule May Avoid Relapse of Chronic Hepatis C
Abstract: Interferon (IFN) alpha is the only drug active in the therapy of chronic B and C hepatitis (CHB and CHC) and is active in several types of cancer especially Hairy Cell Leukaemia, Chronic Myeloid Leukaemia and melanoma. The present therapeutic schedules use an almost continuous administration of IFN in spite of the fact..
-
Irish Hospital Consultant Views on the Management of Hereditary Haemochromatosis and Analysis of the Differences Between 'Common Practice' and The Management Guidelines Available.
Abstract: Background: 0.05% of those with Northern European lineage carry homozygous mutations in the HFE gene causing iron overload. This is a disease with considerable morbidity, which can be screened for. There are many national and regional protocols in place which are somewhat incongruent with each other. We believe that ma..
-
Non Alcoholic Fatty Liver Disease, NAFLD: General Overview of a Multifactorial Disease
Abreviations: NAFLD, Non alcoholic fatty liver disease; NASH, non alcoholic steatohepatitis; HPF, high power field; GH: growth hormone; IGF-1, insulin like growth factor 1; TNF, tumor necrosis factor; IP-10, Interferon gamma induced protein 10; MCP-1, monocytes chemoattractan protein; MTTP, microsomal trygliceride transfer protein; ..
- View all
No WMC Peer Reviewed articles Found!
- Latest ReviewsView all